← Leaderboards
Stuart Farquharson
Real-Time Analyzers, Inc.
$1,290,634
Attributed
$1,290,634
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $530.7K · FY2012–15$1M$750K$500K$250K$0
'12
'13
'14
'15
Funding mix
By agency
NIH$1,290,634 · 3
By mechanism
R44$1,034,138 · 1
R43$256,496 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Performance”
- Jeffrey P Krischer · University Of South Florida$413,069,911
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$378,749,497
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$319,618,139
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Research focus
PerformanceReagentImmunoassayOutpatientsPortabilityRaman Spectrum AnalysisDiagnosisDrug TestingMedicalMonitorIllicit DrugsPharmaceutical PreparationsProgramsHealth PersonnelBaseDevicesCocaineCompliance BehaviorLaboratoriesMeasurementDiazepamMeetingsDrug UsageRehabilitation Centers
Grant awards (4)
Saliva Analyzer for Diagnosing SRD Patient Drug Use$503,459
R44 · FY2015 · DA · contact PI
Saliva Analyzer for Diagnosing SRD Patient Drug Use$530,679
R44 · FY2014 · DA · contact PI
Saliva Analyzer for Diagnosing SRD Patient Drug Use$156,535
R43 · FY2012 · DA · contact PI
Chemotherapy Drug Analyzer$99,961
R43 · FY2002 · CA